NeueHealth, Inc. (NYSE:NEUE) CFO Jay Matushak Sells 4,448 Shares

NeueHealth, Inc. (NYSE:NEUE) CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares in the company, valued at $280,330.08. This trade represents a 9.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Jay Matushak also recently made the following trade(s):

• On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The stock was sold at an average price of $6.85, for a total transaction of $5,575.90.
• On Friday, March 7th, Jay Matushak sold 1,860 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total transaction of $13,373.40.
• On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10.

NeueHealth Trading Up 9.4 %

Shares of NYSE:NEUE opened at $5.10 on Wednesday. The stock has a market capitalization of $42.25 million, a PE ratio of -0.10 and a beta of 0.56. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $7.66. The firm has a fifty day moving average price of $7.16 and a 200 day moving average price of $6.01.

Institutional Investors Weigh In On NeueHealth

A number of large investors have recently bought and sold shares of NEUE. Virtu Financial LLC bought a new stake in NeueHealth in the fourth quarter worth $76,000. Northern Trust Corp boosted its holdings in NeueHealth by 66.8% during the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after acquiring an additional 13,074 shares during the period. Finally, Partners Group Holding AG bought a new stake in NeueHealth during the third quarter valued at about $463,000. 63.88% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Royal Bank of Canada decreased their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.